The Role of Levosimendan as Inotropic Agent in Acute Aluminum Phosphide-induced Cardiotoxicity
Clinical trial NCT06478667 · COMPLETED
Trial details
- NCT number
- NCT06478667
- Sponsor
- Ain Shams University
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-20
- Primary completion
- 2025-01-20
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.